09:38 EDT Nuvectis Pharma Inc trading halted, volatility trading pause
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVCT:
- Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer
- Nuvectis Pharma reports FY23 EPS ($1.43) vs ($1.51) last year
- Nuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results and Business Highlights
- NVCT Upcoming Earnings Report: What to Expect?
- Correction: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences